At the center of the gene expression cascade, translation is fundamental in defining the fate of much of the transcribed genome. RNA sequencing enables the quantification of complex transcript mixtures, often detecting several splice isoforms of unknown functions for one gene. We have developed ORFquant, a new approach to annotate and quantify translation at the single open reading frame (ORF) level, using information from Ribo-seq data. Relying on a novel approach for transcript filtering, we quantify translation on thousands of ORFs, showing the power of Ribo-seq in revealing alternative ORFs on multiple isoforms per gene. While we find that one ORF represents the dominant translation product for most genes, we also detect genes with translated ORFs on multiple transcript isoforms, including targets of RNA surveillance mechanisms. Assessing the translation output across human cell lines reveals the extent of gene-specific differences in protein production, which are supported by steady-state protein abundance estimates. Computational analysis of Ribo-seq data with ORFquant (available at https://github.com/lcalviell/ORFquant) provides a window into the heterogeneous functions of complex transcriptomes.
Introduction
Studying gene expression allows us to understand the functions of different molecules and regulatory sequence elements, whether they act at the level of transcription, the transcribed RNA, or the encoded protein. To ensure correct protein synthesis, transcriptional and post-transcriptional regulatory programs determine the identity and amount of mature RNA templates. The translation process ensures the correct identity and amount of synthesized proteins.
The ribosome is the main actor of the translation process, a complex ribonucleoparticle that is not only able to synthesize proteins, but also acts as quality control platform for both the nascent peptide 1 and the translated mRNA 2 . Several RNA surveillance mechanisms are known to occur co-translationally, and their importance for different processes such as differentiation or disease has been investigated 3 .
Ribosome profiling (Ribo-seq) has made it possible to pinpoint the positions of actively translating ribosomes transcriptome-wide, using ribosome footprinting coupled to RNA sequencing 4 . In the last decade, Ribo-seq has been extensively used to investigate the molecular mechanisms acting on the ribosome, and to identify the entire ensemble of translated regions (the translatome) in multiple organisms and conditions. The resulting rich datasets have triggered a plethora of dedicated analysis methods, which exploit distinct features of Ribo-seq profiles to confidently identify translated ORFs 5, 6 . In this context, many reports have focused on whether small translated regions are hidden in long noncoding RNAs [7] [8] [9] , with less attention given so far to account for the presence of multiple transcript isoforms per gene.
Transcript diversity can result from either alternative splicing (AS) or from alternative transcription start or poly-adenylation site usage, and it is now commonly profiled by RNA-seq experiments, which measure steady-state abundance of (m)RNAs. Large-scale efforts have uncovered the wide spectrum of alternative transcript isoforms, with many being lowly expressed and/or presenting incomplete ORFs 10 . The contribution of this transcript heterogeneity to an expanded translatome is therefore an intensely debated topic 11, 12 , with much of transcript and protein abundance apparently explained by a single dominant transcript per gene 13 .
The mere presence of multiple transcripts does not imply the presence of a distinct, functional protein translated from each transcript isoform: transcripts might be retained in the nucleus, selectively degraded, or undergo translational repression. From a technical point of view, RNA-seq experiments quantify a complex scenario in which, depending on the protocol used, alternative transcripts may also reflect different steps of RNA processing and not the stable, steady-state cytoplasmic pool of mRNAs available to the ribosome. From a different direction, shotgun proteomics approaches are only recently providing the sensitivity to detect tens of thousands of proteins from a single sample 14 and rarely reach the depth to investigate alternative protein isoforms.
To close this gap, we developed a strategy to identify and quantify translation on the subset of transcripts that are expressed in the cell. A recent study presented a proof-of-principle for validating the presence of multiple transcript isoforms in Ribo-seq data 15 , underlining the potential of isoform-aware analysis approaches to fully define the translatome. Following up on this premise, we here describe ORFquant, a Ribo-seq analysis approach that detects and quantifies ORF translation across multiple transcript isoforms and zooms in on the potential roles of alternative transcripts.
Results
The ORFquant approach to annotate and quantify translation Our approach is based on the premise that, despite their short length, Ribo-Seq reads are sufficient to support a given set of alternative transcripts (Figure 1a, b ). Single-nucleotide positions corresponding to the peptidyl-site for each ribosome (P-sites positions) and junction reads are first extracted from the Riboseq alignment (Methods) and then mapped to flattened gene models from a given annotation ( Figure 1b ).
In this way, transcript features (e.g. exonic bins or splice junctions) are designated as unique or shared across multiple annotated transcript isoforms.
We first retain a subset of annotated transcripts, which is sufficient to explain all the observed P-sites or junction reads and reduce the occurrence of exons and junctions with no signal, using an Occam's razor strategy (Methods). In brief, a transcript is filtered out if its features supported Ribo-seq signal can be explained by another transcript with better support (i.e. containing more features with Ribo-seq support or fewer unsupported features). As Ribo-seq reads are largely found in 5'UTRs and coding regions only, this approach might not distinguish between transcripts differing in their 3'UTR.
This simple yet effective selection strategy leads to a significantly reduced number of transcripts: the observed Ribo-seq signal can be explained by 1 to 3 transcript structures for most genes, without showing a strong bias for expression level (Figure 1c, Supplementary Figure 1 ). This selection dramatically improves 4 the assignments of both exons and junctions to transcripts ( Figure 1d ): when considering covered exons or junctions (defined as having at least one Ribo-seq read mapped to them), ~64% of exons mapped to 1 or 2 transcripts, compared to ~29% when no selection is performed. Considering only annotated proteincoding transcripts does not substantially improve the mapping of covered features, while it ignores the presence of covered exons and junctions unique to non-coding transcripts. Next, we detect translated ORFs de novo in each of the selected transcripts, using frame preference and the multitaper [16] [17] [18] test to select in-frame signal displaying 3nt periodicity (Methods), a hallmark of active translation elongation.
Detected ORFs are filtered using the same strategy used for transcript filtering.
After calculating coverage on unique and shared ORF features (exonic bins and splice junctions within ORF boundaries), a scaling factor between 0 and 1 is determined using the coverage on unique ORF features, or the amount of overlap between ORFs when no unique feature can be detected (Methods). This scaling factor represents the fraction of Ribo-seq signal which can be assigned to that ORF. The scaled number of P-sites is then normalized by the ORF length to arrive at transcripts per million (TPM) 19 -like values, named ORFs per Million ("ORFs_pM"). Moreover, we calculate the relative contribution of each ORF to the overall translation output of each gene ("ORF_pct_P_sites", or percentage of gene translation). An additional filtering step discards poorly translated ORFs. ORFs are then annotated according to their position relative to their host transcript, to other detected ORFs in the same gene, and to annotated CDS regions.
Applying ORFquant, we quantified translation for ~20,800 ORFs in ~12,300 genes profiled in a Ribo-Seq data set from the human HEK293 cell line 18 . Most genes (7, 732 Figure 1e ) displayed only one translated ORF, with another >5,000 genes showing translation of multiple ORFs. Upon closer inspection (Figure 1f ), we observed that for the majority of genes (~80%), the most translated (i.e., major) ORF could explain >80% of the total gene translation, with only 444 genes for which the major ORF explained <50% of the translational output. We did not observe a clear dependency between number of detected ORFs (or % of translation of major ORF) and overall Ribo-seq coverage, with the exception of the few dozen genes for which the major ORF accounted for little of the total gene output ( Supplementary Figure 1) .
In principle, the final set of ORFs can be provided to any algorithm for transcript quantification. To demonstrate the effectiveness of our simple approach, we compared our estimates with the ones calculated by RSEM 19 , a well-known statistical approach devoted to transcript quantification. We observed good correlation between the two method in their estimates of the relative contribution of each ORF to the total output ( Supplementary Figure 2 , left). In addition, we observed how RSEM quantification estimates showed high uncertainty (Methods) for ORFs where few unique features are present, which are cases where ORFquant assigns low translation estimates to the major ORF ( Supplementary Figure 2 , right).
Despite major differences in their quantification strategy (Discussion), both ORFquant and RSEM showed similar performances in determining the contribution of each ORFs to the total gene translation output.
To illustrate the consistency of our translation estimates, we annotated the ORF structures with respect to the major (most translated) ORFs in each gene: this allowed us to detect genomic regions (e.g. different alternative splice sites) where the Ribo-seq signal should reflect different quantitative estimates of translation coming from different ORF(s). Aggregate profiles of Ribo-seq coverage closely reflected the expected pattern calculated by ORFquant (Figure 1g ). Additional profiles over different genomic locations are shown in Supplementary Figure 3 . Taken together, the translation of a major ORF accounts for >80% of total gene translation for most of the genes, but distinct translated ORFs are detected from multiple translated transcripts for hundreds of genes.
Quantification of translation as a window into the functional relevance of alternative open reading frames
As translation is a cytoplasmic process, we expected the ensemble of transcript structures selected by ORFquant to represent bona fide cytoplasmic transcripts. To test this hypothesis, we performed a differential exon usage analysis 20 , using RNA-seq data from nuclear and cytoplasmic extracts in HEK293 cells 21 . Most exons unique to discarded structures showed marked nuclear localization (log2FC>0), while exons of selected transcripts showed a prominent cytoplasmic enrichment (Figure 2a ). Translated transcripts displayed a more marked cytoplasmic localization. An example of the selection strategy discarding pre-mRNA structures in favor of cytoplasmic transcripts is shown in Figure 2b .
When examining the GENCODE annotation 22 of the transcripts hosting de novo identified ORFs, we noticed ~2,000 ORFs in non-coding transcript isoforms of protein-coding genes, most of which lacked annotated ORFs (Figure 2c ). Compared to ORFs in annotated protein-coding transcript isoforms, these ORFs exhibited much lower translation, accounting for a median of 6.8 % of gene translation, compared to 87% for ORFs that fully matched annotated CDSs. More than 3,500 N-terminal truncation events were also detected, showing high levels of translation. Upstream ORFs (uORFs) and other small ORFs exhibited low signal, albeit high when normalized by their length. In annotated non-coding genes, we detected 181 ORFs from annotated pseudogenes and 620 ORFs from other non-coding RNA genes, with overall lower translation levels than protein-coding RNAs (Figure 2c ).
Analysis of a deep polysome profiling dataset (Trip-Seq 23 ) from the same cell line showed that the quantitative estimates of translation agreed with distinct polysome profiles (Figure 2d The presence of numerous lowly translated ORFs detected in non-coding transcript isoforms ( Figure 2c) suggested inefficient translation and/or low steady-state abundance of the translated transcript. We wondered whether transcripts subject to RNA surveillance mechanisms (such as nonsense-mediated decay, NMD) might cause such a low but detectable Ribo-seq signal. The presence of a premature termination codon (PTC) is an important feature of many NMD targets 24 , which is assumed to be recognized as such when the stop codon is located sufficiently upstream of the last splice junction, i.e. when a downstream Exon Junction Complex (EJC) is not displaced during translation elongation ( Figure   3a ). To investigate the putative action of NMD on PTC-containing transcripts, we divided transcripts based on the presence of a splice site downstream of a detected ORF. A recent study mapped NMD-mediated cleavage events on the transcriptome in HEK293 cells 25 , by knocking down XRN1, the exonuclease in charge of degrading the cleaved transcripts. When aligning the cleavage sites at the stop codons of (putative) PTC-and non-PTC-containing transcripts (from the same genes), we observed a clear difference ( Figure 3b ): transcripts without PTC, i.e. where all EJCs are presumably displaced, showed backgroundlike signal, while transcripts harboring a putative PTC showed a marked degradation profile around their stop codon 24 . The degradation signal was less pronounced when SMG6 or UPF1 were also knocked-down, underlining the effect of known key factors of the NMD pathway on our candidate NMD targets. A clear example of such pattern is visible on a translated ORF in the SNHG17 gene ( Figure 3c ).
To further explore the dependency of NMD with regards to the location of PTCs as well as the transcript type, we determined the number of endonucleolytic cuts at the stop codon as a function of PTC distance to the last exon-exon junction. We observed an increase in degradation for NMD candidate ORFs for all the surveyed ORFs (including uORFs; Figure 3d ). As previously reported 25 , ORFs in snoRNA host genes (such as SNHG17, Figure 3c ) showed the highest degradation profile, while other categories exhibited a lower amount of degradation. In summary, ORFquant is an efficient method to identify mature mRNAs, quantify the translation output of different transcript isoforms from the same gene, and to infer transcript-specific cytoplasmic fates.
A subset of genes translates different major ORFs in different cell lines
To investigate the patterns of alternative ORF usage across different conditions, we ran ORFquant on Riboseq datasets from 6 different human cell lines (Supplementary Table 1 , Supplementary Data 1, Figure 4a ), with newly generated data for K562 and HepG2 cell lines complementing previously published libraries from HEK293, HeLa, U2OS and Jurkat cells 18, [26] [27] [28] . For each dataset we observed the same trend described in Figure 1d , with most genes showing translation of one major ORF, and hundreds of genes showing sustained translation of multiple ORFs, with a weak dependency on the overall Ribo-seq signal ( Supplementary Figures 5, 6 ). Across all cell lines, we detected ORF translation for ~17,000 genes (excluding pseudogenes), with ~89% of them annotated as protein-coding genes.
For each gene and cell line, we defined the major ORF as the most translated ORF from a gene, regardless of its positional features and existing ORF annotation. For ~77% of the quantified genes, the same ORF was consistently identified as the major translated ORF in all the assayed cell lines ( Figure 4b ). For ORFs in non-coding RNAs, we detect a more cell-specific pattern of major ORF usage. However, a few dozen non-coding genes displayed translation of the same major ORF: one such example is again SNHG17, where the translation of an ORF terminating at a PTC ( Figure 3c ) is consistently detected across the assayed cell lines ( Figure 4c ).
As expected, genes translated in all cell lines showed overall higher Ribo-seq signal. However, we did not observe a clear dependence between number of distinct major ORFs across cell lines and overall gene translation ( Supplementary Figure 7) . Two or more distinct major ORFs were identified in 18% and 5% of genes, representing candidate major ORF switching events across cell lines (Figure 4b ). At a closer look, we observed that genes translating multiple major ORFs also displayed a more complex mixture of translated ORFs. Consequently, translation of the major ORF for those genes accounted for a lower percentage of total gene translation ( Figure 4b Taken together, these translation estimates indicate that the presence of one dominant ORF agrees across multiple cell lines for the majority of genes. For ~20% of the translated genes, however, highly translated small ORFs and/or several transcripts expressed at sustained levels create a substantial level of complexity in protein synthesis, with distinct ORFs accounting for the majority of the gene translational output in different cell lines.
Agreement between protein abundance and synthesis estimates depends on proteome coverage and transcriptome complexity
Ribo-seq reflects the density of elongation-competent 80S ribosome, and thus active protein synthesis, but an increased signal at a specific location may also represent stalled, inactive ribosomes. We therefore examined whether our translation quantification reflects the abundance of the synthesized protein product. Using a comprehensive custom protein database derived from the set of identified ORFs ( Supplementary Figure 12 , Supplementary Data 2), we estimated proteome-wide steady-state protein abundance using published deep mass spectrometry data 30, 31 for the same cell lines outlined above ( Figure   4a ). We detected between 7,000 and 8,000 proteins per cell line ( Supplementary Figure 13 Figure 14) .
When comparing the fraction of total gene translation to the fraction of total gene protein abundance for the few dozen genes with mass spectrometry matches to multiple detected protein isoforms, we observed a correlation of 0.58 (Figure 5c ). Here, only few proteins harbored >9 uniquely mapping peptides, thus limiting our ability in reliably estimating their abundance (Figure 5a ). We observed lower correlations when skipping the ORF-specific scaling step during translation quantification, highlighting the importance of accounting for the presence of multiple translated ORFs per gene (Figure 5c ). The same pattern was observed for the other cell lines analyzed (Figure 5d, Supplementary Figure 15 ). A slight increase in correlations was detected when using all Ribo-seq reads (instead of uniquely mapping reads only) to derive translation estimates ( Supplementary Figure 16 ), likely resulting from a better quantification in repetitive regions.
Taken together, these results show excellent correlations between ORFquant quantification and steadystate protein abundance, subject to the limitations in coverage that leads to lower agreement between Ribo-seq and shotgun proteomics.
Discussion
Only a fraction of known, annotated transcript structures are expressed in a specific context, and only a fraction of those structures are exported to the cytoplasm and eventually translated into functional proteins. This observation inspired us to devise a simple strategy to identify the subset of translated ORFs across transcript isoforms from Ribo-seq data, by discarding a substantial fraction of transcript structures with no support. The marked nuclear localization of annotated but discarded RNAs (Figure 2a ) indicates that these structures are not present at translating ribosomes, i.e. that they are not expressed in the assayed condition or that they represent pre-mRNA intermediates which are either rapidly degraded or retained in the nucleus. Our strategy therefore resulted in a markedly improved mapping of Ribo-seq exonic and junction reads to their possible transcripts of origin (Figure 1d ), allowing for ORF-specific translation estimates.
The quantification of transcript isoform expression is a well-studied problem in RNA-seq, with popular methods applying iterative methods (such as the expectation-maximization algorithm) to resolve the mixture resulting from multiple transcripts 19, 32, 33 . However, resolving the mixture of multiple transcript isoforms can be challenging for some genes, especially in the absence of coverage on unique transcript features. We could show how a top performing algorithm designed to solve this problem with high accuracy displays high variability in its estimates for such cases (Supplementary Figure 2) , illustrating how short-read sequencing data, such as resulting from Ribo-seq, does not provide sufficient information to impeccably quantify translation for each and every gene. The rapidly increasing availability of full-length transcript sequence data based on long-read sequencing 34 holds great promise in solving these complex scenarios.
While polysome profiling experiments (Figure 2d ) and label-free quantification of the protein product ( Figure 5b ) support the Ribo-seq-based estimates of relative ORF translation levels, we believe that additional efforts can improve ORF-specific quantification of translation. A more accurate approach will have to address the issue of variable Ribo-seq coverage along the ORFs, which reflects the complex dynamics of translation. However, the impact of different features, such as experimental biases, codon composition or RNA structural features 35 , on Ribo-seq coverage remain to be understood. Our approach also uses a strict definition of ORFs that requires a canonical start codon and does not account for overlapping frames. It is still an open question how to correctly define the precise boundaries of translated elements that account for non-canonical start codons and signals from overlapping frames, such as from upstream ORFs 36 or complex gene structures in compact genomes such as found in viruses and organelles.
Our strategy enabled us to detect thousands of lowly translated ORFs in transcript isoforms of protein coding genes that are annotated as non-coding, consistent with current models for mRNA surveillance such as NMD (Figure 3) . Similarly, we observed that many detected ORFs in non-coding RNAs show high degradation profiles at their stop codons, especially pronounced in snoRNA host genes (Figure 3d ). This well-known phenomenon is therefore important to consider when addressing the protein-coding ability of transcripts based on ribosome occupancy. In turn, the ability to identify NMD target candidates can provide an advantageous starting point for further research into defining the features of co-translational mRNA surveillance and its links to protein quality control 37 .
Expanding our analysis across multiple cell lines allowed us to assess the complexity of translation per gene for both coding and non-coding genes (Figure 4b ). We found the majority of genes to be translating the same major ORF (including highly translated ORFs in non-coding RNAs, Figure 4c ), but we also detected distinct ORFs used for the major translation product in different cell lines in thousands of genes. These genes showed an overall more complex pattern of transcript expression, with sustained translation of many transcripts, and thus posing a difficulty in defining clear isoform switching event. In this context, the presence of highly translated small ORFs in protein-coding genes ( Supplementary Figure 11) , which may play gene regulatory roles rather than expand the proteome, adds further complexity. Unfortunately, the limited amount of data at hand (often lacking replicate information) and the heterogeneity of protocols adopted by different labs, pose challenges to precisely quantify the contribution of different mechanisms in promoting diversity (or lack thereof) in protein synthesis.
Despite potential limitations, we observed a substantial agreement between our estimates of translation and steady-state protein abundance. The level of agreement between mRNAs and proteins has been subject to intense debate 38 ; our results indicate that for thousands of genes, shotgun proteomics experiments and sequencing of ribosome-occupied RNA fragments do show excellent agreement, albeit with expected dependencies on the reliability with which we can quantify the levels of translation and protein abundance (Figure 5a ). An increasing availability of Ribo-seq and proteomics data in a single controlled environment will improve our understanding of this relationship and help to pinpoint interesting cases in which this correlation deviates from expectation. While our analyses provide a promising starting point for the investigation of transcript-specific protein production, the current scarcity of matching data specifically limits our ability to validate the translation of alternative protein isoforms per gene. A recent study demonstrated how protein isoforms engage with distinct protein-protein interaction networks, with such interactions being as different as the ones involving proteins from distinct genes 39 . With both proteomics 40, 41 and transcriptomics 42 techniques rapidly advancing at a fast pace, our study demonstrates the unique advantage of ribosome profiling in characterizing and quantifying cytoplasmic gene expression programs, at the interface between RNA and protein.
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Dobin if % has more positive features than # , or fewer negative internal features than # , # is discarded ii)
All the positive features of % are also contained in # :
if # has fewer negative internal features than % , % is discarded.
This greedy strategy reduces the number of transcripts that is necessary to cover all the positive features (features with reads), trying to minimize the presence of negative features (features with no reads). We select ORFs following the same rules, this time using exonic bins and splice junctions derived from the ORF structures.
ORFquant -ORF finding
As in the RiboTaper 18 method, only ATG is considered as potential start codon, and the p-value for the multitaper method applied to the candidate ORF P-sites track must be below 0.05. To select ORFs with in-frame P-sites and account for local off-frame effects, we require the average signal on each covered codon to be >50% in frame. The same strategy is used to select the start codon for each ORF, requiring >50% average in-frame codon signal between each candidate ATG and the next.
ORFquant -ORF quantification
After the ORF finding step, ORF filtering and quantification is subsequently performed, using the length- The scaling factor is again derived dividing the average shared coverage (attributed to the ORF) to total average coverage.
CD8 = R><=>][
R><=>RTT After the calculation of CD8 , the adjusted number of P-sites for each ORF ( CD8 ) is calculated using the raw number of P-sites mapping to the ORF multiplied by the scaling factor, to obtain ORF-specific quantification estimates.
CD8 = * CD8
For each ORF of length CD8 , the scaled numbers of P-sites CD8 is normalized over the entire set of 
Normalization by length is here not applied, as this metric wants to quantify the amount of translation per gene coming from each ORF. The ORF_pct_P_sites_pN metric indicates length-normalized
ORF_pct_P_sites values (e.g. they can be high for a short highly translated ORF).
After quantification, ORFs are subjected to a filtering step and quantification is performed again, until all
ORFs are being retained.
20
ORFquant parameters For all cell lines, ORFquant was run using a cutoff of 2% of total gene translation and using only uniquely mapping reads.
RSEM quantification: RSEM 1.3.1 was run in strand-specific mode on Ribo-seq data using a seed length of 20, using Bowtie2 as aligner, and enabling the calculation of confidence intervals together with posterior mean estimates.
ORFquant-derived ORF positions were used to specify the transcript sequences to use as reference.
When possible, additional 15 nucleotides were added to start and end coordinates to allow for the mapping of Ribo-seq reads. The "TPM_coefficient_of_quartile_variation" column of the RSEM output was used as a proxy to monitor the variability in RSEM quantification estimates.
Ribosome profiling:
Ribo-seq was performed as described previously 18 Suspension cells were supplemented with 100 ug/ml cycloheximide, pelleted for 5 min at 300 g and washed with ice-cold PBS + 100 ug/ml cycloheximide. The washed cell pellet was immediately snap-frozen in liquid nitrogen. 400 ul of ice-cold lysis buffer was added, and the cells were put on wet ice to thaw, mixing them using a pipet tip.
The cells were left to lyse for 10 min on ice, followed by 10x trituration through a 26-G needle. After centrifugation for 10 min at 20'000g at 4°C the clarified supernatant was transferred to a pre-cooled tube on ice. For nuclease footprinting, 400 ul of lysate were supplemented with 1000 U of RNase I (Life Tech.
#AM2295) and incubated in a thermomixer set to 23°C, shaking at 500 rpm for 45 min. Footprinting was stopped by adding 260 U of SUPERASE-In (Life Tech. #2696).
To recover ribosomes two MicroSpin S-400 HR columns (GE Healthcare #27-5140-01) per 400 ul of sample were equilibrated with a total of 3 ml of polysome buffer. The columns were drained by spinning for 4 min at 600 g, then the sample was applied and spun for 2 min at 600g. Three volumes of Trizol LS (Life To prepare the RNA sample for use in a smallRNA library preparation kit the sample was phosphorylated Ribo-seq and RNA-seq data processing
Ribo-seq reads were stripped of their adapters using cutadapt 43 Polysome profiling:
DEXSeq 20 was run to detect differential exon usage between each of the polysome fraction and the cytoplasmic abundance. Transcripts were divided based on the translation levels of their translated ORF(s) and intersected with differential exons (FDR<0.01 in at least one polysome fraction). Only genes with multiple translated transcripts were used.
Nuclear-cytoplasmic comparison:
DEXSeq 20 was run to detect differential exon usage between the nuclear and the cytoplasmic fraction.
Differential exons (FDR<0.01) were intersected with transcript structures and only exons uniquely mapping to one transcript group (e.g. discarded transcripts, selected transcripts etc…) were selected. 23 
5'end of endonucleolytic cuts:
Bigwig files for the different libraries were normalized by library size. Coordinates were lifted to hg38 and overlapped with ORFquant-identified stop codon positions, for both NMD candidates and controls ("canonical" stop codons taken from the same genes). A window of 50 nucleotides was used to derive spatial profiles and count the number of reads mapping around stop codons in the different conditions.
Merging ORFquant result across cell lines:
ORFs were considered to be distinct if they ended at different stop codons or could not be mapped to the same transcript. Enrichments for ORF categories at different level of overlap were calculated using normalized residuals from a chi-squared test. GO enrichment was performed using the clusterProfiler 48 and topGO 49 packages.
Proteomics database search:
Raw data was searched using MaxQuant 31 version 1.6.0.13, using Carbamidomethyl as fixed modification, and oxidation of Methionine and acetylation at protein N-termini as variable modifications. Quantification was performed using only unique peptides. Matching between runs was enabled. We used a custom database to perform the peptide search: ORFquant-detected ORFs were merged in a unique database, choosing only ORFs explaining a minimum of 10% of gene translation in at least one cell line.
Comparison between protein abundance and translation estimates:
For each protein group, iBAQ values were summed up for each replicate. ORFs_pM values were summed for all ORFs mapping to each protein group. ORF_pct_iBAQ values were obtained by dividing each iBAQ value for the sum iBAQ values for that gene. Protein groups mapping to multiple genes were discarded.
The same procedure was applied to ORFs_pM values, to compare protein and translation estimates for each protein isoform. Only proteins detected by Ribo-seq (or RNA-seq) and proteomics were used. Genelevel TPM values in Supplementary Figure 14 were calculated using kallisto 32 with default parameters.
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Data availability
Ribo-seq data for HepG2 and K562 is available at GEO under the accession X. Ribo-seq datasets for other cell lines were previously published, and accessed using the accessions GSE79664 (HeLa), GSE73136
(HEK293), GSE74279 (Jurkat) and GSE56924 (U2OS); more details about the analyzed samples can be found in Supplementary Table 1 . Nuclear and cytoplasmic RNA-seq was accessed at the European Nucleotide Archive using the accession PRJEB4197. TriP-seq data was downloaded from GEO using the accession GSE69352. Transcriptome-wide tracks of 5' ends were accessed using the accession GSE57433. 
Code availability
ORFquant is available at https://github.com/lcalviell/ORFquant. Supplementary Table 1 : Summary of Ribo-seq datasets analyzed in this study. 
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